Big Shock…..Do we ❤ POCUS?
‘Red Standby 4 mins’ tannoys the nurse in charge. ‘It’s a 70yr old male BP 68/49, pulse 120, GCS 14/15, O2 sats 98% on 15L NRB, temperature 37.5°C’ you are […]
Big Shock…..Do we ❤ POCUS? Read More
Explore essential critical care topics, including sepsis, respiratory failure, haemodynamic support, and trauma resuscitation. Our evidence-based posts provide practical guidance on managing critically ill patients in emergency and acute care settings.
‘Red Standby 4 mins’ tannoys the nurse in charge. ‘It’s a 70yr old male BP 68/49, pulse 120, GCS 14/15, O2 sats 98% on 15L NRB, temperature 37.5°C’ you are […]
Big Shock…..Do we ❤ POCUS? Read More
Although this post is mainly about the new Anaphylaxis Guidelines published recently, please bear with me while we get a little nerdy with some physiology first… For anyone starting out
Anaphylaxis – A Guideline Update Read More
The prevention of venous thromboembolism (VTE) has been a real concern in the management of hospitalised patients with COVID-19. We have previously discussed the role of prophylactic anticoagulation (thromboprophylaxis) for
JC: Thromboprophylaxis on the ICU for COVID-19 patients. St Emlyn’s Read More
The latest results on the use of convalescent plasma in Covid-19 are now out from the RECOVERY trial as a pre-print. As you know we have already covered the trial
JC: Convalescent plasma (still) does not work in COVID-19. St Emlyn’s Read More
Cricothyroidotomy is a procedure that worried many emergency physicians. Partly because it’s a rare procedure, but also because we are likely to embarking on it at a time when things
JC: Real world cricothyroidotomy experience. St Emlyn’s Read More
It’s very rare we produce three instalments on one particular drug for one particular condition, and certainly not within such a short time frame. However, tocilizumab has been worth it.
Tocilizumabulous? A special offer on IL-6 with Tocilizumab. Read More
In arguably the most important therapeutic news of the pandemic since Dexamethasone, the RECOVERY trial investigators have revealed the initial results on the Tocilizumab arm of the trial showing a
JC: RECOVERY trial shows Tocilizumab effective for COVID19. St Emlyn’s Read More
Oxygen targets in critically ill/injured patients has been something we’ve talked about on the blog before. In general the evidence to date has suggested that the routine prescription of oxygen
Oxygen targets in critical care: The HOT-ICU trial. St Emlyn’s Read More